GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
last added cars
2022-10-20| In-Depth

Leveraging Synthetic Biology, Microbiome-based Therapies Open Up Possibilities for Clinical Applications

by GeneOnline
Share To
Among all areas of development in synthetic biology, microbiome therapy is one of the most rapidly advancing and highly anticipated areas of technology. As the science community uncovers the close relationship between microbial ecology and human health, microbiomes are regarded as a “second genome” apart from the human genome, with extensive effects on gastrointestinal health, chronic diseases, cancer, and psychological disorders. As a result, clinical applications of microorganisms are becoming increasingly prevalent, ranging from therapeutics, diagnostics,  disease prevention, and novel carriers of therapeutic molecules. Companies and institutions are testing these in clinical trials, and regulatory agencies have approved some for marketing as derivative pharmaceutical products. With the main focus on microbiome therapy, this feature article will provide an in-depth overview of this promising technology's technical principles, clinical applications, and future trends.

GO Prime with only $1.49 now

LATEST
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
2025-02-13
NASA Says There’s a 1 in 43 Chance an Asteroid 2024 YR4 Could Hit Earth in 2032—Should We Worry?
2025-02-13
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-04
MIXiii Health-Tech.IL
Jerusalem, Israel
2025-03-05
Medical Japan
Osaka, Japan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress 2025
Washington, U.S.A
Scroll to Top